Literature DB >> 3142910

Muscle and adipose tissue morphology and metabolism in Cushing's syndrome.

M Rebuffé-Scrive1, M Krotkiewski, J Elfverson, P Björntorp.   

Abstract

Femoral and abdominal adipose tissue cellularity and metabolism as well as muscle morphology and metabolism were examined in women with Cushing's syndrome and compared with those in nonobese women and obese women with the android and gynoid types of fat distribution. Cushing's syndrome was characterized by abdominal obesity and enlarged abdominal fat cells, with adipose tissue lipoprotein lipase activity elevated 2-3 times that in normal women and low lipolytic capacity. Muscle tissue in women with Cushing's syndrome had a relatively low proportion of type I (30%) and a high proportion of type IIB (32%) muscle fibers, similar to those in android obesity (45% and 25%, respectively) and in contrast to fiber composition in gynoid obesity (55% and 12%, respectively). Glycogen synthase activity in the lateral vastus muscle was very low. We suggest that the enlargement of abdominal fat depots in women with Cushing's syndrome is at least partially due to elevated adipocyte lipoprotein lipase activity and low lipolytic activity. Furthermore, the abnormal muscle fiber composition might be caused by the corticosteroid excess. Such muscle is known to be relatively insulin insensitive and might thus contribute to the marked insulin resistance that occurs during chronic corticosteroid excess.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142910     DOI: 10.1210/jcem-67-6-1122

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  37 in total

Review 1.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

2.  Biomarkers of Psychological Stress in Health Disparities Research.

Authors:  Zora Djuric; Chloe E Bird; Alice Furumoto-Dawson; Garth H Rauscher; Mack T Ruffin; Raymond P Stowe; Katherine L Tucker; Christopher M Masi
Journal:  Open Biomark J       Date:  2008-01-01

3.  Association of perceived neighborhood safety with [corrected] body mass index.

Authors:  Jason S Fish; Susan Ettner; Alfonso Ang; Arleen F Brown
Journal:  Am J Public Health       Date:  2010-09-23       Impact factor: 9.308

4.  Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells.

Authors:  J Aubert; C Darimont; I Safonova; G Ailhaud; R Negrel
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

Review 5.  Insulin receptor/IRS-1/PI 3-kinase signaling system in corticosteroid-induced insulin resistance.

Authors:  F Folli; M J Saad; C R Kahn
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

6.  Cortisol and the muscle-bone axis: response to comments by Molfino et al.

Authors:  A Scillitani; G Mazziotti; C Di Somma; S Moretti; A Stigliano; R Pivonello; A Giustina; A Colao
Journal:  Osteoporos Int       Date:  2015-03-06       Impact factor: 4.507

7.  Leptin inhibits cortisol and corticosterone secretion in pathologic human adrenocortical cells.

Authors:  N Szücs; I Varga; C Jakab; A Patócs; E Gláz; M Tóth; R Kiss; K Rácz
Journal:  Pituitary       Date:  2001 Jan-Apr       Impact factor: 4.107

Review 8.  Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

Authors:  Eliza B Geer; Julie Islam; Christoph Buettner
Journal:  Endocrinol Metab Clin North Am       Date:  2014-03       Impact factor: 4.741

Review 9.  Skeletal muscle insulin resistance in endocrine disease.

Authors:  Melpomeni Peppa; Chrysi Koliaki; Panagiotis Nikolopoulos; Sotirios A Raptis
Journal:  J Biomed Biotechnol       Date:  2010-03-15

10.  Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men.

Authors:  S K Fried; C D Russell; N L Grauso; R E Brolin
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.